ERIC DOBMEIER Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
ERIC DOBMEIER in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
Holdings: 121,153 shares
Current Value: $7,364,891
Latest Transaction: Dec 06 2017
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC DOBMEIER in Seagen Inc.
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.29 | 10,635 | 109,434 | 74,811 | |
| Apr 26 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.20 | 14,365 | 146,523 | 0 | |
| Apr 26 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 19.95 | 10,635 | 212,168 | 68,073 | 78.7 K to 68.1 K (-13.51 %) |
| Apr 26 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.29 | 10,635 | 109,434 | 78,708 | 68.1 K to 78.7 K (+15.62 %) |
| Apr 26 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 19.95 | 14,365 | 286,582 | 68,073 | 82.4 K to 68.1 K (-17.43 %) |
| Apr 26 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.20 | 14,365 | 146,523 | 82,438 | 68.1 K to 82.4 K (+21.10 %) |
| Feb 29 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.33 | 18,229 | 188,306 | 0 | |
| Feb 29 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.20 | 27,771 | 283,264 | 14,365 | |
| Feb 29 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 18.52 | 27,771 | 514,330 | 72,073 | 99.8 K to 72.1 K (-27.81 %) |
| Feb 29 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.20 | 27,771 | 283,264 | 99,844 | 72.1 K to 99.8 K (+38.53 %) |
| Feb 29 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 18.52 | 18,229 | 337,608 | 72,073 | 90.3 K to 72.1 K (-20.19 %) |
| Feb 29 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.33 | 18,229 | 188,306 | 90,302 | 72.1 K to 90.3 K (+25.29 %) |
| Dec 22 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 4.45 | 10,000 | 44,500 | 5,397 | |
| Dec 22 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 4.45 | 10,000 | 44,500 | 71,843 | 61.8 K to 71.8 K (+16.17 %) |
| Nov 10 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 5.25 | 2,516 | 13,209 | 0 | |
| Nov 10 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 5.25 | 2,516 | 13,209 | 61,843 | 59.3 K to 61.8 K (+4.24 %) |
| Oct 27 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 5.92 | 10,835 | 64,143 | 0 | |
| Oct 27 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 5.81 | 10,083 | 58,582 | 0 | |
| Oct 27 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 21.95 | 10,835 | 237,828 | 59,327 | 70.2 K to 59.3 K (-15.44 %) |
| Oct 27 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 5.92 | 10,835 | 64,143 | 70,162 | 59.3 K to 70.2 K (+18.26 %) |
| Oct 27 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 21.95 | 10,083 | 221,322 | 59,327 | 69.4 K to 59.3 K (-14.53 %) |
| Oct 27 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 5.81 | 10,083 | 58,582 | 69,410 | 59.3 K to 69.4 K (+17.00 %) |
| Oct 21 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 6.74 | 20,461 | 137,907 | 0 | |
| Oct 21 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 20.58 | 20,461 | 421,024 | 59,327 | 79.8 K to 59.3 K (-25.64 %) |
| Oct 21 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 6.74 | 20,461 | 137,907 | 79,788 | 59.3 K to 79.8 K (+34.49 %) |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 15.46 | 86,422 | 1,336,084 | 86,422 | |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 15.46 | 245 | 3,788 | 245 | |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 17,334 | 0 | 59,327 | 42 K to 59.3 K (+41.28 %) |
| Aug 24 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 7,886 | 0 | 41,993 | 34.1 K to 42 K (+23.12 %) |
| Aug 03 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 5.25 | 25,000 | 131,250 | 2,516 | |
| Aug 03 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 5.25 | 25,000 | 131,250 | 33,817 | 8.8 K to 33.8 K (+283.54 %) |
| Jul 01 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 20.52 | 32,812 | 673,302 | 32,812 | |
| Jul 01 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 20.52 | 4,688 | 96,198 | 4,688 | |
| Jun 21 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 20.00 | 13,385 | 267,700 | 8,817 | 22.2 K to 8.8 K (-60.29 %) |
| Jun 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 20.00 | 3,600 | 72,000 | 22,202 | 25.8 K to 22.2 K (-13.95 %) |
| May 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.92 | 29,165 | 172,657 | 0 | |
| May 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.81 | 13,550 | 78,726 | 0 | |
| May 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 18.00 | 29,165 | 524,970 | 25,802 | 55 K to 25.8 K (-53.06 %) |
| May 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.92 | 29,165 | 172,657 | 54,967 | 25.8 K to 55 K (+113.03 %) |
| May 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 18.00 | 13,550 | 243,900 | 25,802 | 39.4 K to 25.8 K (-34.43 %) |
| May 13 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.81 | 13,550 | 78,726 | 39,352 | 25.8 K to 39.4 K (+52.52 %) |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.81 | 16,367 | 95,092 | 13,550 | |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.63 | 16,292 | 91,724 | 0 | |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 4.45 | 7,341 | 32,667 | 0 | |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 16.00 | 7,341 | 117,456 | 25,802 | 33.1 K to 25.8 K (-22.15 %) |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 7,341 | 32,667 | 33,143 | 25.8 K to 33.1 K (+28.45 %) |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 16.00 | 16,292 | 260,672 | 25,802 | 42.1 K to 25.8 K (-38.70 %) |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.63 | 16,292 | 91,724 | 42,094 | 25.8 K to 42.1 K (+63.14 %) |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 16.00 | 16,367 | 261,872 | 25,802 | 42.2 K to 25.8 K (-38.81 %) |
| Apr 07 2011 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.81 | 16,367 | 95,092 | 42,169 | 25.8 K to 42.2 K (+63.43 %) |
| Dec 23 2010 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 4,000 | 21,000 | 27,516 | |
| Dec 23 2010 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 4,000 | 21,000 | 24,242 | 20.2 K to 24.2 K (+19.76 %) |
| Sep 07 2010 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 12.00 | 116,667 | 1,400,004 | 116,667 | |
| Sep 07 2010 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 12.00 | 8,333 | 99,996 | 8,333 | |
| Nov 02 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 5,000 | 26,250 | 31,516 | |
| Nov 02 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 4.45 | 1,985 | 8,833 | 15,397 | |
| Nov 02 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 1,985 | 8,833 | 19,609 | 17.6 K to 19.6 K (+11.26 %) |
| Nov 02 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 5,000 | 26,250 | 17,624 | 12.6 K to 17.6 K (+39.61 %) |
| Aug 26 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 12.16 | 91,777 | 1,116,008 | 91,777 | |
| Aug 26 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 12.16 | 8,223 | 99,992 | 8,223 | |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.63 | 21,989 | 123,798 | 16,292 | |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 15,734 | 79,771 | 0 | |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 4.45 | 11,745 | 52,265 | 7,341 | |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 4.45 | 3,532 | 15,717 | 19,086 | |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.36 | 11,745 | 145,202 | 12,206 | 24 K to 12.2 K (-49.04 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 11,745 | 52,265 | 23,951 | 12.2 K to 24 K (+96.22 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.36 | 21,989 | 271,848 | 12,206 | 34.2 K to 12.2 K (-64.30 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.63 | 21,989 | 123,798 | 34,195 | 12.2 K to 34.2 K (+180.15 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.36 | 7,000 | 86,549 | 12,206 | 19.2 K to 12.2 K (-36.45 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.36 | 3,532 | 43,670 | 19,206 | 22.7 K to 19.2 K (-15.53 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 3,532 | 15,717 | 22,738 | 19.2 K to 22.7 K (+18.39 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.36 | 15,734 | 194,537 | 19,206 | 34.9 K to 19.2 K (-45.03 %) |
| Jul 31 2009 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 15,734 | 79,771 | 34,940 | 19.2 K to 34.9 K (+81.92 %) |
| Dec 16 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 5,000 | 26,250 | 36,516 | |
| Dec 16 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 5,000 | 26,250 | 19,000 | 14 K to 19 K (+35.71 %) |
| Sep 30 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 5,000 | 26,250 | 41,516 | |
| Sep 30 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 5,000 | 26,250 | 14,000 | 9 K to 14 K (+55.56 %) |
| Sep 30 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 11.53 | 24,427 | 281,575 | 9,000 | 33.4 K to 9 K (-73.08 %) |
| Sep 18 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 10,000 | 50,700 | 15,734 | |
| Sep 18 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 4.45 | 20,000 | 89,000 | 22,618 | |
| Sep 18 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.25 | 20,000 | 244,970 | 33,427 | 53.4 K to 33.4 K (-37.43 %) |
| Sep 18 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 4.45 | 20,000 | 89,000 | 53,427 | 33.4 K to 53.4 K (+59.83 %) |
| Sep 18 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Sell | S | 12.25 | 10,000 | 122,485 | 33,427 | 43.4 K to 33.4 K (-23.03 %) |
| Sep 18 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.07 | 10,000 | 50,700 | 43,427 | 33.4 K to 43.4 K (+29.92 %) |
| Aug 29 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 11.09 | 100,983 | 1,119,901 | 100,983 | |
| Aug 29 2008 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | A | 11.09 | 9,017 | 99,999 | 9,017 | |
| Dec 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 5,000 | 26,250 | 46,516 | |
| Dec 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 5,000 | 26,250 | 29,427 | 24.4 K to 29.4 K (+20.47 %) |
| Sep 27 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 10,000 | 52,500 | 51,516 | |
| Sep 27 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 3.30 | 5,417 | 17,876 | 0 | |
| Sep 27 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 2.77 | 5,212 | 14,437 | 0 | |
| Sep 27 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 3.30 | 5,417 | 17,876 | 24,427 | 19 K to 24.4 K (+28.50 %) |
| Sep 27 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 5.25 | 10,000 | 52,500 | 19,010 | 9 K to 19 K (+110.99 %) |
| Sep 27 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Buy | M | 2.77 | 5,212 | 14,437 | 9,010 | 3.8 K to 9 K (+137.23 %) |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 0 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 200 | 1,050 | 400 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 300 | 1,575 | 600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 300 | 1,575 | 900 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 1,200 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 300 | 1,575 | 1,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 300 | 1,575 | 1,900 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,300 | 6,825 | 2,200 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 600 | 3,150 | 3,500 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 3,327 | 17,467 | 4,100 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 3,373 | 17,708 | 7,427 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,900 | 9,975 | 10,800 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 600 | 3,150 | 12,700 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 800 | 4,200 | 13,300 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 900 | 4,725 | 14,100 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 2,042 | 10,721 | 15,000 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 700 | 3,675 | 17,042 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,658 | 8,705 | 17,742 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 800 | 4,200 | 19,400 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 20,200 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 20,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,800 | 9,450 | 21,000 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 2,784 | 14,616 | 22,800 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,664 | 8,736 | 25,584 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 2,052 | 10,773 | 27,248 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 300 | 1,575 | 29,300 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 29,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 200 | 1,050 | 30,000 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 30,200 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 800 | 4,200 | 30,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,100 | 5,775 | 31,400 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 900 | 4,725 | 32,500 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,200 | 6,300 | 33,400 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,400 | 7,350 | 34,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 36,000 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,100 | 5,775 | 36,400 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 600 | 3,150 | 37,500 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 282 | 1,481 | 38,100 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 500 | 2,625 | 38,382 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 500 | 2,625 | 38,882 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 518 | 2,720 | 39,382 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 4,700 | 24,675 | 39,900 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,300 | 6,825 | 44,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 45,900 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 100 | 525 | 46,300 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 300 | 1,575 | 46,400 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,300 | 6,825 | 46,700 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 600 | 3,150 | 48,000 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 3,480 | 18,270 | 48,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,300 | 6,825 | 52,080 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 2,220 | 11,655 | 53,380 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,400 | 7,350 | 55,600 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 1,800 | 9,450 | 57,000 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 400 | 2,100 | 58,800 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.25 | 183 | 961 | 59,200 | |
| Sep 21 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Business Offi ... | Option Exercise | M | 5.07 | 717 | 3,635 | 25,734 |